Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.

Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA.

Alcohol Clin Exp Res. 2010 Nov;34(11):1849-57. doi: 10.1111/j.1530-0277.2010.01273.x.

2.

Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.

Ponizovsky AM, Rosca P, Aronovich E, Weizman A, Grinshpoon A.

J Subst Abuse Treat. 2015 May;52:24-30. doi: 10.1016/j.jsat.2014.11.007. Epub 2014 Dec 2.

PMID:
25572706
3.

[Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].

Krupitsky EM, Rybakova KV, Kiselev AS, Alexeeva YV, Berntsev VA, Chekhlaty EI, Zubova EY, Popov YV, Neznanov NG.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):53-62. doi: 10.17116/jnevro20151156153-62. Russian.

PMID:
26356398
4.

Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety.

Morley KC, Baillie A, Leung S, Addolorato G, Leggio L, Haber PS.

Alcohol Alcohol. 2014 Nov;49(6):654-60. doi: 10.1093/alcalc/agu062. Epub 2014 Sep 21.

5.

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.

Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G.

Alcohol Alcohol. 2002 Sep-Oct;37(5):504-8.

PMID:
12217947
6.

Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.

Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R; Baclofen Study Group.

Alcohol Alcohol. 2011 May-Jun;46(3):312-7. doi: 10.1093/alcalc/agr017. Epub 2011 Mar 17.

PMID:
21414953
7.

High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.

Müller CA, Geisel O, Pelz P, Higl V, Krüger J, Stickel A, Beck A, Wernecke KD, Hellweg R, Heinz A.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1167-77. doi: 10.1016/j.euroneuro.2015.04.002. Epub 2015 Apr 14.

PMID:
26048580
8.

The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.

Hauser P, Fuller B, Ho SB, Thuras P, Kern S, Dieperink E.

Addiction. 2017 Jul;112(7):1173-1183. doi: 10.1111/add.13787. Epub 2017 Apr 2.

PMID:
28192622
10.

Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.

Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G.

Alcohol Clin Exp Res. 2000 Jan;24(1):67-71.

PMID:
10656195
11.

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.

Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41.

PMID:
12634260
12.

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R; NCIG 002 Study Group.

Alcohol Clin Exp Res. 2012 Aug;36(8):1421-30. doi: 10.1111/j.1530-0277.2011.01716.x. Epub 2012 Feb 10.

13.

Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.

Addolorato G, Leggio L.

Curr Pharm Des. 2010;16(19):2113-7. Review.

PMID:
20482507
14.

Baclofen for alcohol dependence: a preliminary open-label study.

Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A.

Alcohol Clin Exp Res. 2004 Oct;28(10):1517-23.

PMID:
15597084
15.
16.

A human laboratory pilot study with baclofen in alcoholic individuals.

Leggio L, Zywiak WH, McGeary JE, Edwards S, Fricchione SR, Shoaff JR, Addolorato G, Swift RM, Kenna GA.

Pharmacol Biochem Behav. 2013 Feb;103(4):784-91. doi: 10.1016/j.pbb.2012.11.013. Epub 2012 Dec 19.

17.

Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.

Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W.

J Clin Psychiatry. 2003 Dec;64(12):1440-8.

PMID:
14728105
18.

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.

Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O'Brien CP.

J Clin Psychopharmacol. 2007 Aug;27(4):344-51.

19.

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.

Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, Pettinati H, Swift R, Afshar M, Brunette MF, Tiouririne NA, Kampman K, Stout R; NCIG 001 Study Group.

Alcohol Clin Exp Res. 2012 Mar;36(3):406-16. doi: 10.1111/j.1530-0277.2011.01649.x. Epub 2011 Sep 26.

20.

Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.

[No authors listed]

Prescrire Int. 2013 Sep;22(141):214-7. Review.

PMID:
24171218

Supplemental Content

Support Center